Cipta Sarana Medika Tbk. vs Sarimelati Kencana Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Sarimelati Kencana Tbk. trades at Rp185 (market cap 553B, 3.72M 24h volume). The key difference: Sarimelati Kencana Tbk. is far larger — about 3.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 3.72M). Which is the better fit depends on your goals.
| DKHH | PZZA | |
|---|---|---|
Market Cap | 158.12B | 553B |
Volume | 8.21M | 3.72M |
Lot | 82.15K | 37.22K |
Turnover | 515.2M | 666.16M |
Average Price | 62.72 | 179 |
Value | 515.2M | 666.16M |
Indicative Equilibrium Price | 63 | 185 |
Indicative Equilibrium Volume | 1.33K | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Read more on PZZA →